IRS2 and lung adenocarcinoma: Bowel, breast, and lung tissues are enriched with double mutations in specific genes whereas brain tissue has significant but rare double mutations in multiple genes such as FGFR1, IRS2, POLE, and TP53. LUAD (Lung Adenocarcinoma) is enriched with EGFR double mutations.